KEY PRODUCTS
With Fermion, start the journey of your innovative API.
01 1Fermion Oy
01 1METHOTREXATE
01 1Finland
01 1Active
01 1Complete
With Fermion, start the journey of your innovative API.
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-08
Pay. Date : 2013-05-23
DMF Number : 4246
Submission : 1981-08-06
Status : Active
Type : II
20
Fermion Oy, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for With Fermion, start the journey of your innovative API.
One of their notable products is METHOTREXATE, with a corresponding US DMF Number 4246.
Remarkably, this DMF maintains an Active status since its submission on August 06, 1981, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 08, 2013, and payment made on May 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
